GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI) » Definitions » Change In Inventory

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Change In Inventory : €-14.3 Mil (TTM As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Laboratorios Farmaceuticos Rovi Change In Inventory?

Laboratorios Farmaceuticos Rovi's change in inventory for the quarter that ended in Mar. 2024 was €2.7 Mil. It means Laboratorios Farmaceuticos Rovi's inventory declined by €2.7 Mil from Dec. 2023 to Mar. 2024 .

Laboratorios Farmaceuticos Rovi's change in inventory for the fiscal year that ended in Dec. 2023 was €-29.3 Mil. It means Laboratorios Farmaceuticos Rovi's inventory increased by €29.3 Mil from Dec. 2022 to Dec. 2023 .

Laboratorios Farmaceuticos Rovi's Total Inventories for the quarter that ended in Mar. 2024 was €338.0 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Laboratorios Farmaceuticos Rovi's Days Inventory for the quarter that ended in Mar. 2024 was 470.80.

Inventory Turnover measures how fast the company turns over its inventory within a year. Laboratorios Farmaceuticos Rovi's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.19.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Laboratorios Farmaceuticos Rovi's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 2.24.


Laboratorios Farmaceuticos Rovi Change In Inventory Historical Data

The historical data trend for Laboratorios Farmaceuticos Rovi's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorios Farmaceuticos Rovi Change In Inventory Chart

Laboratorios Farmaceuticos Rovi Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -67.23 -70.40 -23.43 -71.59 -29.29

Laboratorios Farmaceuticos Rovi Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.26 -27.81 -13.19 23.96 2.70

Laboratorios Farmaceuticos Rovi Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-14.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laboratorios Farmaceuticos Rovi  (XMAD:ROVI) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Laboratorios Farmaceuticos Rovi's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=337.9695/65.505*365 / 4
=470.80

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Laboratorios Farmaceuticos Rovi's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Laboratorios Farmaceuticos Rovi's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Laboratorios Farmaceuticos Rovi Change In Inventory Related Terms

Thank you for viewing the detailed overview of Laboratorios Farmaceuticos Rovi's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Business Description

Traded in Other Exchanges
Address
Julian Camarillo, 35, Madrid, ESP, 28037
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Headlines

From GuruFocus

Rovi Corp: Profitability in Times of Change

By Damian Illia Damian Illia 02-19-2014

Rovi Corp. (ROVI) President and CEO Alfred J Amoroso sells 33,957 Shares

By GuruFocus Research GuruFocus Editor 01-05-2011

Rovi Corp. (ROVI) President and CEO Alfred J Amoroso sells 96,461 Shares

By GuruFocus Research GuruFocus Editor 03-04-2011

Rovi Corp. (ROVI) EVP & CFO James Budge sells 44,145 Shares

By GuruFocus Research GuruFocus Editor 03-04-2011